Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883453503> ?p ?o ?g. }
- W2883453503 endingPage "227" @default.
- W2883453503 startingPage "221" @default.
- W2883453503 abstract "IL-35 is an immunosuppressive cytokine that is largely synthesized by regulatory T (Treg) cells and may inhibit antitumor immune responses. This investigation aimed to determine the serum IL-35 concentrations and a single nucleotide polymorphism (SNP) in position of rs3761548, within the promoter region of FOXP3 gene, in patients with prostate cancer (PC). The blood specimens were obtained from 150 PC patients prior to using radiation therapy, chemo- or immunotherapy and 150 age-matched healthy men as a control group. The serum IL-35 concentrations and the pattern of genetic variation at position of rs3761548 were assessed using ELISA and polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP), respectively. The mean serum IL-35 concentrations were significantly higher in PC patients when compared with healthy control group (20.01 ± 7.03 Pg/mL vs. 11.60 ± 2.49 Pg/mL, P < 0.001). The serum IL-35 concentrations raised with progression of PC stages so that there was a significant difference between PC stages concerning the IL-35 concentrations (P < 0.001). The mean serum IL-35 concentrations in patients with Gleason scores of 1–6 and Gleason scores 7–10 were significantly higher as compared with healthy controls (P < 0.001). Moreover, the serum IL-35 concentrations in patients with having Gleason scores of 7–10 were significantly higher as compared with patients with Gleason scores of 1–6 (P < 0.001). Evaluation of the genetic variations in position SNP rs3761548 revealed that the AA genotype and A allele were more prevalent whereas CC genotype and C allele were less prevalent in PC patients when compared with healthy men (P < 0.01, P < 0.001, P < 0.002 and P < 0.001, respectively). The AA genotype and A allele were associated with higher risk of PC incidence [OR: 2.42 (95% CI: 1.179–4.99); P < 0.001 and OR: 1.732 (95% CI: 1.244 – 2.413); P < 0.001, respectively]. The mean serum IL-35 concentrations were significantly higher in total subjects (PC patients + healthy individuals) with AA genotype and A allele than individuals with CC genotype and C allele at SNP rs3761548 (P < 0.05 and P < 0.01, respectively). Higher serum IL-35 concentrations observed in patients with PC that were increased with progressive tumor stages. These findings indicate that the IL-35 is possibly involve in tumor progression. Moreover, SNP rs3761548 may affect the susceptibility to PC and the serum IL-35 concentrations." @default.
- W2883453503 created "2018-08-03" @default.
- W2883453503 creator A5017493185 @default.
- W2883453503 creator A5019642763 @default.
- W2883453503 creator A5049462917 @default.
- W2883453503 creator A5078834482 @default.
- W2883453503 creator A5083712060 @default.
- W2883453503 creator A5085113824 @default.
- W2883453503 date "2019-01-01" @default.
- W2883453503 modified "2023-10-16" @default.
- W2883453503 title "Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer" @default.
- W2883453503 cites W1002798955 @default.
- W2883453503 cites W1995378816 @default.
- W2883453503 cites W2010098090 @default.
- W2883453503 cites W2020537499 @default.
- W2883453503 cites W2042923170 @default.
- W2883453503 cites W2057030367 @default.
- W2883453503 cites W2057281059 @default.
- W2883453503 cites W2074171712 @default.
- W2883453503 cites W2077442400 @default.
- W2883453503 cites W2085469373 @default.
- W2883453503 cites W2118094114 @default.
- W2883453503 cites W2119799287 @default.
- W2883453503 cites W2139621564 @default.
- W2883453503 cites W2141841595 @default.
- W2883453503 cites W2167849861 @default.
- W2883453503 cites W2168285096 @default.
- W2883453503 cites W2256034989 @default.
- W2883453503 cites W2262673463 @default.
- W2883453503 cites W2297581901 @default.
- W2883453503 cites W2518249323 @default.
- W2883453503 cites W2521412203 @default.
- W2883453503 cites W2546466212 @default.
- W2883453503 cites W2558317907 @default.
- W2883453503 cites W2600603820 @default.
- W2883453503 cites W2601766294 @default.
- W2883453503 cites W2605225622 @default.
- W2883453503 cites W2612204637 @default.
- W2883453503 cites W2623437005 @default.
- W2883453503 cites W2734982560 @default.
- W2883453503 doi "https://doi.org/10.1016/j.cyto.2018.07.006" @default.
- W2883453503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30057362" @default.
- W2883453503 hasPublicationYear "2019" @default.
- W2883453503 type Work @default.
- W2883453503 sameAs 2883453503 @default.
- W2883453503 citedByCount "21" @default.
- W2883453503 countsByYear W28834535032019 @default.
- W2883453503 countsByYear W28834535032020 @default.
- W2883453503 countsByYear W28834535032021 @default.
- W2883453503 countsByYear W28834535032022 @default.
- W2883453503 countsByYear W28834535032023 @default.
- W2883453503 crossrefType "journal-article" @default.
- W2883453503 hasAuthorship W2883453503A5017493185 @default.
- W2883453503 hasAuthorship W2883453503A5019642763 @default.
- W2883453503 hasAuthorship W2883453503A5049462917 @default.
- W2883453503 hasAuthorship W2883453503A5078834482 @default.
- W2883453503 hasAuthorship W2883453503A5083712060 @default.
- W2883453503 hasAuthorship W2883453503A5085113824 @default.
- W2883453503 hasConcept C104317684 @default.
- W2883453503 hasConcept C121608353 @default.
- W2883453503 hasConcept C126322002 @default.
- W2883453503 hasConcept C135763542 @default.
- W2883453503 hasConcept C139275648 @default.
- W2883453503 hasConcept C153209595 @default.
- W2883453503 hasConcept C180754005 @default.
- W2883453503 hasConcept C203014093 @default.
- W2883453503 hasConcept C2776235491 @default.
- W2883453503 hasConcept C2779727006 @default.
- W2883453503 hasConcept C2780192828 @default.
- W2883453503 hasConcept C54355233 @default.
- W2883453503 hasConcept C71924100 @default.
- W2883453503 hasConcept C86803240 @default.
- W2883453503 hasConcept C8891405 @default.
- W2883453503 hasConcept C90924648 @default.
- W2883453503 hasConceptScore W2883453503C104317684 @default.
- W2883453503 hasConceptScore W2883453503C121608353 @default.
- W2883453503 hasConceptScore W2883453503C126322002 @default.
- W2883453503 hasConceptScore W2883453503C135763542 @default.
- W2883453503 hasConceptScore W2883453503C139275648 @default.
- W2883453503 hasConceptScore W2883453503C153209595 @default.
- W2883453503 hasConceptScore W2883453503C180754005 @default.
- W2883453503 hasConceptScore W2883453503C203014093 @default.
- W2883453503 hasConceptScore W2883453503C2776235491 @default.
- W2883453503 hasConceptScore W2883453503C2779727006 @default.
- W2883453503 hasConceptScore W2883453503C2780192828 @default.
- W2883453503 hasConceptScore W2883453503C54355233 @default.
- W2883453503 hasConceptScore W2883453503C71924100 @default.
- W2883453503 hasConceptScore W2883453503C86803240 @default.
- W2883453503 hasConceptScore W2883453503C8891405 @default.
- W2883453503 hasConceptScore W2883453503C90924648 @default.
- W2883453503 hasLocation W28834535031 @default.
- W2883453503 hasOpenAccess W2883453503 @default.
- W2883453503 hasPrimaryLocation W28834535031 @default.
- W2883453503 hasRelatedWork W2056355462 @default.
- W2883453503 hasRelatedWork W2107074164 @default.
- W2883453503 hasRelatedWork W2117622607 @default.
- W2883453503 hasRelatedWork W2283861756 @default.
- W2883453503 hasRelatedWork W2358154819 @default.